Improved local diagnosis of focal hyperinsulinism in the COVID-19 era by interstate radiopharmaceutical transport
J Paediatr Child Health
.
2023 Feb;59(2):398-400.
doi: 10.1111/jpc.16307.
Epub 2022 Dec 13.
Authors
Joel Vanderniet
1
2
3
,
Kristen A Neville
1
4
,
Louise S Conwell
5
6
,
Eva A Wegner
7
8
,
Maria E Craig
2
3
4
,
Susan Adams
4
9
,
Andrew J Gifford
4
10
,
Melissa Koutsiofi
7
,
Frances M Calabria
7
,
Gemma Maguire
11
,
Paul Thomas
6
11
,
Louise Campbell
11
,
Helen J Woodhead
1
4
Affiliations
1
Department of Endocrinology, Sydney Children's Hospital, Sydney, New South Wales, Australia.
2
Department of Paediatrics, St George Hospital, Sydney, New South Wales, Australia.
3
Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
4
School of Paediatrics and Child Health, University of New South Wales, Sydney, New South Wales, Australia.
5
Department of Endocrinology and Diabetes, Queensland Children's Hospital, Brisbane, Queensland, Australia.
6
Greater Brisbane Clinical School, The Medical School, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
7
Department of Nuclear Medicine and PET, Prince of Wales and Sydney Children's Hospitals, Sydney, New South Wales, Australia.
8
School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
9
Department of Paediatric Surgery, Sydney Children's Hospital, Sydney, New South Wales, Australia.
10
Anatomical Pathology, NSW Health Pathology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
11
Department of Nuclear Medicine and Specialised PET Services Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
PMID:
36511518
DOI:
10.1111/jpc.16307
No abstract available
Publication types
Case Reports
MeSH terms
COVID-19 Testing
COVID-19*
Congenital Hyperinsulinism*
Humans
Hyperinsulinism*
Infant
Pancreas
Radiopharmaceuticals
Substances
Radiopharmaceuticals